425: Strive & Semler Scientific Merger Update

Strive, Inc. CEO Matthew Cole reposts communication regarding the proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. CEO Matthew Cole reposted a communication on X.com on December 29, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication highlights forward-looking statements related to the merger's outlook, strategic and financial benefits, expected impact on future financial performance, closing timing, and integration success.
• Investors are cautioned about inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, to register Class A common stock for the transaction.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek their approval for the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a procedural update and a cautionary statement regarding forward-looking information related to a proposed merger. It balances the announcement of the merger's progression with extensive disclosure of associated risks and uncertainties, preventing a strongly positive or negative sentiment.

Positives

• The proposed business combination between Strive and Semler Scientific is progressing, with Strive having filed a Registration Statement on Form S-4.
• The transaction is anticipated to yield strategic and financial benefits for the combined company.

Negatives

• The filing primarily focuses on cautionary statements regarding forward-looking information, indicating significant risks and uncertainties associated with the proposed merger.
• Potential for the anticipated benefits, including cost savings and strategic gains, not to be realized.
• Risk of dilution for Strive shareholders due to the issuance of additional Class A common stock.

Risks

• The merger agreement could be terminated due to unforeseen events, changes, or circumstances.
• The proposed transaction may not close when expected or at all if closing conditions are not met timely.
• Potential for legal proceedings against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, such as cost savings and strategic gains, may not be realized, possibly due to issues with Bitcoin treasury strategies, general economic conditions, interest/exchange rates, monetary policy, or regulatory changes.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution of Strive's Class A common stock due to the issuance of additional shares in connection with the transaction.
• Potential adverse reactions from customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The future outlook is centered on the successful completion and integration of the proposed business combination between Strive and Semler Scientific, with expectations of strategic and financial benefits. However, this outlook is subject to significant risks and uncertainties, including the possibility that the transaction may not close as expected, benefits may not be realized, or integration could be more challenging than anticipated.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted the communication on X.com on December 29, 2025.

Industry Context

The filing does not provide specific industry context beyond the fact that two companies are merging. The mention of 'Bitcoin treasury strategies' suggests an involvement or interest in digital assets, which could be a relevant industry trend for one or both companies.

Legal Proceedings

• The filing mentions the possibility that legal proceedings may be instituted against Strive or Semler Scientific or the combined company, which is a risk factor.

Stakeholder Impact

• Shareholders: Potential for dilution of Strive's Class A common stock, changes in share price, and the need for Semler Scientific stockholders to approve the transaction.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.

Next Steps

• Semler Scientific stockholders need to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus.

Key Dates

Recommendation

This filing is a procedural update regarding an ongoing business combination, primarily serving as a cautionary statement about forward-looking information and associated risks. While the merger itself could be a strategic positive, the extensive list of potential risks and uncertainties, including integration challenges, dilution, and the possibility of the transaction not closing, warrants a cautious stance. Investors should hold existing positions and await further definitive information, particularly the outcome of the shareholder vote and more detailed financial projections for the combined entity, before making new investment decisions.

Keywords

Strive Inc., Semler Scientific Inc., merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, corporate governance, investment, stockholders, Bitcoin treasury strategies